MB 7
Alternative Names: MB-7Latest Information Update: 10 Jun 2024
At a glance
- Originator Must Bio
- Class Antineoplastics; Recombinant fusion proteins; Trispecific antibodies
- Mechanism of Action Programmed cell death 1 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 30 May 2024 Early research in Solid tumours in South Korea (Parenteral) (Must Bio pipeline, May 2024)